NeoGenomics Reports Revenue of $125 Million in the Second Quarter

Go back to NeoGenomics Reports Revenue of $125 Million in the Second Quarter
NEOGENOMICS (NASDAQ: NEO) Delayed: 19.33 -0.23 (1.18%)
Previous Close $19.56    52 Week High $9.54 
Open $19.56    52 Week Low $5.49 
Day High $19.75    P/E 483.25 
Day Low $18.87    EPS $0.04 
Volume 2,019,691